http://www.inboxrobot.com/news/lymphomaConstantly updated news and information about a variety of topics. http://www.inboxrobot.com/news.php?fid=191999170 8 Oct 2008 02:45 GMT ... advancing the medical care industry for companion animals by establishing state-of-the-art treatment centers for lymphoma and other forms of cancer throughout the country. The company's focus is on furthering ... http://www.inboxrobot.com/news.php?fid=191991367 8 Oct 2008 01:56 GMT ... advancing the medical care industry for companion animals by establishing state-of-the-art treatment centers for lymphoma and other forms of cancer throughout the country. The company's focus is on furthering ... http://www.inboxrobot.com/news.php?fid=191989839 8 Oct 2008 01:37 GMT ... advancing the medical care industry for companion animals by establishing state-of-the-art treatment centers for lymphoma and other forms of cancer throughout the country. The company's focus is on furthering ... http://www.inboxrobot.com/news.php?fid=191987627 8 Oct 2008 01:30 GMT ... below 50 cells/mm3 and most had prior AIDS diagnoses). The cancers included Kaposi's sarcoma, lymphoma, squamous cell carcinoma, hepatocellular carcinoma and anal cancer. Most subjects had other risk factors ... http://www.inboxrobot.com/news.php?fid=191979903 8 Oct 2008 00:58 GMT ... debate about whether it's a carcinogen and it's most closely associated with leukemia and lymphoma. The best scientific opinion says any amount of exposure is dangerous and more exposure ... http://www.inboxrobot.com/news.php?fid=191979060 8 Oct 2008 00:54 GMT ... first approved in 1997 in the United States to treat a form of non-Hodgkin’s lymphoma. Two years ago, the drug received approved a wider scope as a lymphoma treatment, ... http://www.inboxrobot.com/news.php?fid=191973501 7 Oct 2008 23:43 GMT ... MabThera is indicated for the treatment of previously untreated patients with stage III-IV follicular lymphoma in combination with chemotherapy. MabThera maintenance therapy is indicated for patients with relapsed/refractory follicular ... http://www.inboxrobot.com/news.php?fid=191960758 7 Oct 2008 22:05 GMT ... quick with jokes. Specter, who recently underwent a second round of chemotherapy for Hodgkin's lymphoma, told the crowd he felt good, then quipped, "I ought to shave my head ... http://www.inboxrobot.com/news.php?fid=191959896 7 Oct 2008 21:57 GMT ... BIIB) discovered Rituxan, an antibody, and it was approved in 1997 to treat non-Hodgkin’s lymphoma. Later it was approved for other uses, including against rheumatoid arthritis. Researchers said the ... http://www.inboxrobot.com/news.php?fid=191959075 7 Oct 2008 21:36 GMT ... member of the Women Presidents' Organization (WPO). Diane volunteers time to the Leukemia and Lymphoma Society, serves on the marketing committee for Triangle Family Services, is a board member ... http://www.inboxrobot.com/news.php?fid=191950673 7 Oct 2008 20:51 GMT ... > SBS Group Lights The Night for The Leukemia & Lymphoma Society WOODBRIDGE, NEW JERSEY October 7, 2008 SBS Group Lights The Night ... http://www.inboxrobot.com/news.php?fid=191950171 7 Oct 2008 20:37 GMT ... controlled pivotal Phase 3 Fast-Tracked clinical trial for the treatment of indolent follicular non-Hodgkin’s lymphoma, an often fatal blood cancer. After a recent meeting with the FDA, the Company ... http://www.inboxrobot.com/news.php?fid=191947860 7 Oct 2008 20:30 GMT ... is facing the toughest challenge of his life -- full recovery from mantle cell lymphoma, a cancer of the immune system. His experiences over the past year and a ... http://www.inboxrobot.com/news.php?fid=191940799 7 Oct 2008 19:28 GMT ... first approved in 1997 in the United States to treat a form of non-Hodgkin’s lymphoma. Two years ago, the drug received approved a wider scope as a lymphoma treatment, ... http://www.inboxrobot.com/news.php?fid=191940293 7 Oct 2008 19:19 GMT ... controlled pivotal Phase 3 Fast-Tracked clinical trial for the treatment of indolent follicular non-Hodgkin's lymphoma, an often fatal blood cancer. After a recent meeting with the FDA, the Company ...